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Background: During nutritional stress, reduced intake may reduce the efficacy of anabolic implants. This study was
conducted to evaluate basic cellular responses to a growth promotant implant at two intake levels.
Methods: Sixteen crossbred steers (293 ± 19.3 kg) were used to evaluate the impact of anabolic implants in either
an adequate or a restricted nutritional state. Steers were trained to individual Calan gates, and then randomly
assigned to 1 of 4 treatments in a 2 × 2 factorial arrangement. Treatments consisted of: presence or absence of an
anabolic growth implant (Revalor-XS, 200 mg TBA and 40 mg estradiol; IMPLANT or CONTROL) and a moderate
energy, pelleted, starting cattle diet fed at either 2.0 × or 1.0 × maintenance energy (NEM) requirements (HIGH or
LOW). Serum (d 0, 14, and 28) was used for application to bovine muscle satellite cells. After treatment with the
serum (20% of total media) from the trial cattle, the satellite cells were incubated for 72 h. Protein abundance of
myosin heavy chain (MHC), phosphorylated extracellular signal-related kinase (phospho-ERK), and phosphorylated
mammalian target of rapamycin (phospho-mTOR) were analyzed to determine the effects of implant, intake, and
their interaction (applied via the serum).
Results: Intake had no effect on MHC (P = 0.85) but IMPLANT increased (P < 0.01) MHC abundance vs. CONTROL.
Implant status, intake status, and the interaction had no effect on the abundance of phospho-ERK (P ≥ 0.23).
Implanting increased phospho-mTOR (P < 0.01) but there was no effect (P ≥ 0.51) of intake or intake × implant.
Conclusions: The nearly complete lack of interaction between implant and nutritional status indicates that the
signaling molecules measured herein respond to implants and nutritional status independently. Furthermore, results
suggest that the muscle hypertrophic effects of anabolic implants may not be mediated by circulating IGF-1.
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Anabolic implants increase average daily gains 15 to
20%, and improve feed efficiency by 6 to 14% in feedlot
cattle [1]. However, when animals first arrive in a feedlot
many are in a state of stress and have not yet become
accustomed to the environment, feeding routine, other
animals, and other factors, especially if they have trav-
eled long distances or have recently been weaned. These
cattle are considered at high risk to develop bovine re-
spiratory disease (BRD). Many of these high-risk cattle* Correspondence: cdr3@ksu.edu
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reproduction in any medium, provided the orhave reduced intakes for up to three weeks after arrival
at the feedlot [2].
Stress and infection can lead to a hypermetabolic state,
characterized by weight loss, increased resting metabolic
rate, and muscle protein catabolism [3]. In cattle infected
with BRD, decreased feed intake, weight loss, and decreased
body condition are often observed [3]. Although ruminants
may have a greater capacity to store digesta because of their
larger digestive tracts, this weight loss and decrease in body
condition may be comparable to the hypermetabolic state
that develops in non-ruminants [3]. Munson et al. [4] re-
ported that delaying implant administration in high-risk
calves did not alter feedlot performance or the risk of re-
spiratory disease, suggesting that stress brought on by theral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Ingredient and nutrient composition (dry matter
basis) of the diet fed during the experimental period
Ingredient, %
Alfalfa meal 33.00
Corn gluten feed, dry 18.18
Wheat middlings 14.63
Distillers grains, dried 11.52
Cracked corn 10.94
Cottonseed hulls 7.75
Molasses, liquid 2.00
Limestone 1.85
Salt 0.10
Bovatec 911 0.025
Vitamin A 650 0.006
Zn SO4 0.0055
Nutrient composition (calculated)2
CP, % 15.31
Ca, % 0.56
P, % 1.43
NEM, Mcal/kg 1.44
NEG, Mcal/kg 0.85
1The final diet contained 49.89 mg lasalocid sodium per kg.
2Nutrient composition calculated based on ingredient composition in the final
diet using tabular estimates of nutrient values (NRC, 1996).
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nals from implanting early in the finishing phase.
Anabolic implants impact growth rate at least in part by
stimulating muscle hypertrophy [5]. Androgenic and estro-
genic steroids increase in vitro bovine satellite cell prolifer-
ation, and these effects are mediated in part by the
extracellular signal-regulated kinase (ERK) and phosphati-
dylinositide 3-kinase/AKT/mammalian target of rapamycin
(mTOR) signaling pathways [6]. Activation of these path-
ways, however, is dependent on adequate nutritional status,
which is sensed through a complex array of signals [7,8].
Therefore, animals in a depleted nutritional state, accom-
panied by alterations in hormonal signals, may not have
the expected muscle growth response to anabolic implants.
The objectives of this study were to examine the ef-
fects of anabolic implants on measures of nutrient bal-
ance, metabolic status, and growth factors in animals
consuming nutrients either adequate or inadequate to
support growth. Moreover, effects of serum-derived sig-
nals on in vitro proliferation of bovine muscle satellite
cells were also assessed.
Materials and methods
Animals
All procedures conducted in the present study were ap-
proved by the Kansas State University Institutional Animal
Care and Use Committee (Protocols 2745.0 and 2745.1).
Sixteen crossbred steers (293 ± 19.3 kg) were purchased
locally and transported to Kansas State University. They
were weighed, tagged, and vaccinated with a 5-way re-
spiratory viral vaccine and a 7-way clostridial vaccine. The
steers were trained to individual Calan® gates over a period
of 4 wk.
After training was complete, the steers were randomly
assigned to 1 of 4 treatments in a 2 × 2 factorial ar-
rangement. Main effect treatments were as follows:
administration or absence of an anabolic implant (Revalor-
XS, 200 mg TBA and 40 mg estradiol 17-β [Merck
Animal Health, Whitehouse Station, NJ]; IMPLANT or
CONTROL, respectively) and either 2.0 × or 1.0 × main-
tenance energy (NEM) requirements of a moderate en-
ergy, pelleted, starting cattle diet (HIGH or LOW,
respectively; Table 1). Energy content of the diet was
calculated from ingredient composition and tabular es-
timates of individual ingredient energy values [9].
Steers were weighed on d 0, 14, and 28 of the trial. At
each of these time points, maintenance energy require-
ments were calculated for each steer [10], and the diet
was fed based these calculations and the treatment as-
signment for each animal.
Biochemical assays
All assays were conducted in duplicate. Satellite cell iso-
lation was conducted as described by Johnson et al. [5].Using sterile techniques, 500 g of the semimembranosus
muscle was dissected from 2 steers which were not part of
the present study (18 mo of age). After removal of con-
nective tissue, the muscle was passed through a sterile
meat grinder. The ground muscle was incubated with
0.1% pronase in Earl’s Balanced Salt Solution (EBSS) for
1 h at 37°C with frequent mixing. After incubation the
mixture was centrifuged at 1,500 × g for 5 min, the pellet
was suspended in phosphate buffered saline (PBS; Ca- and
Mg-free PBS; Life Technologies, Grand Island, NY), and
the suspension was centrifuged at 500 × g for 10 min. The
supernatant was centrifuged at 1,500 × g for 10 min to pel-
let the mononucleated cells. The PBS wash and differential
centrifugation were repeated 2 more times. Cell viability
was over 90%. The resulting mononucleated cell prepar-
ation was suspended, pooled (density 3 × 104 cells/mL) in
cold DMEM containing 10% fetal bovine serum (FBS) and
10% dimethylsulfoxide and frozen in liquid nitrogen. Cells
were counted using a hemocytometer and 0.4% Trypan
Blue solution.
Blood samples (serum and plasma) were collected from
each animal at d 0, 14, and 28 of the trial and used in
determining levels of total IGF-1, and additional serum
samples were collected from each animal for application
to satellite cells [11-13] which had been previously iso-
lated. Total IGF-1 concentration was determined in
plasma samples using a commercial ELISA kit (Octeia
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Inc., Scottsdale, AZ). The kit includes reagents for pre-
treatment of samples to release IGF-1 from binding pro-
teins [14]. Frozen satellite cells were re-suspended in
DMEM supplemented with 5% FBS and 1% penicillin-
streptomycin mixture (containing 10,000 IU/mL penicillin
and 10,000 μg/mL streptomycin). Cells were passaged
once, then at 70% confluence, cells were incubated in
DMEM for 72 h with serum (20% of total media) taken
from individual animals on d 0, 14, or 28 and with an add-
itional control containing 20% FBS and no serum from
trial cattle. Halting incubation at 72 h prevents over-
confluency of the cells, which can lead to excessive differ-
entiation; since these are skeletal muscle cells and would
contract or twitch after differentiation, excessive differenti-
ation would lead the cell layers to come off the cell culture
plate. All media contained 1% penicillin-streptomycin
mixture, but FBS was not added to wells containing treat-
ment serum.
Protein abundance of myosin heavy chain (MHC; d 0,
14, and 28), phosphorylated ERK (phospho-ERK; d 0
and 28), and phosphorylated mTOR (phospho-mTOR;
d 0 and 28) was analyzed in differentiated satellite cells
to determine the effects of implant, intake, and their
interaction (applied via the serum). MHC was used as a
marker of myotube formation, and phospho-ERK and
phospho-mTOR are regulators of cell proliferation.
Western blot analysis
Cultured cells were lysed at 4°C with RIPA lysis buffer
(50 mmol/L Tris–HCl, pH 7.5, 150 mmol/L NaCl, 1% NP-
40, 0.5% sodium deoxycholate, and 0.% SDS; Santa Cruz
Biotechnology, Santa Cruz, CA) containing X1 broad-
spectrum protease inhibitor cocktail (Protease inhibitor
cocktail I; Calbiochem, Gibbstown, NJ) and centrifuged at
15,000 × g for 10 min at 4°C. Protein concentration was
measured using a Coomassie protein assay kit (Pierce,
Rockford, IL) according to Bradford [15]. The proteins in
the supernatant were denatured with SDS buffer contain-
ing dithiothreitol for 5 min at 95°C. Forty micrograms of
protein were loaded in each lane, and proteins were sepa-
rated using SDS-PAGE on a 4 – 12% TRIS-glycine gel,
then transferred to a nitrocellulose membrane (iBlot; Invi-
trogen, Carlsbad, CA). Membranes were blocked in Tris
buffer (pH 7.4) with 5% dry milk powder for 2 h at room
temperature and then incubated with the following anti-
bodies: a rabbit anti-MYH (H-300) polyclonal antibody
raised against amino acids 1641–1940 of myosin heavy
chain 3 (sc-20641; Santa Cruz Biotechnology, Santa Cruz,
CA); rabbit anti-phospho-mTOR (Ser 2481) polyclonal
antibody (Cell Signaling Technology, Beverly, MA), and
rabbit anti-phospho-ERK (Tyr 204; sc-7976, Santa Cruz
Biotechnology) overnight at 4°C. All primary antibodies
were diluted 1:1,000. After washing, membranes wereincubated for 1 h at room temperature with a secondary
antibody (anti-rabbit IgG, sc-2301; Santa Cruz Biotech-
nology) diluted 10,000-fold in Tris buffer (pH 7.4).
Immunodetection was performed by chemilumines-
cence (West-Dura; Thermo Scientific, Waltham, MA),
and band images were visualized using a photodocu-
mentation system (ChemiDoc-It Imaging System; UVP
Inc., Upland, CA). Densitometry analysis was carried
out using Image J (http://rsbweb.nih.gov/ij/).
Statistical analysis
Animal was the experimental unit for all measures. Data
were analyzed using the MIXED procedure of SAS® (v. 9.3;
SAS Institute, Cary, NC); IGF-1 and MHC were analyzed
using repeated measures and d 0 values were included in
the model as a covariate; phospho-ERK and phospho-
mTOR were analyzed as a completely randomized design
but included d 0 values as a covariate. The independent
variables included the main and interactive effects of im-
plant status and intake level. Effects were considered sig-
nificant with a protected F-test with α < 0.05; effects were
considered a trend if P < 0.10.
Results and discussion
Level of feeding achieved different growth rates (0.76 vs.
0.02 kg/d for 2.0 × vs. 1.0 ×maintenance intake, respect-
ively; P < 0.01); implant status did not affect 28-d growth
rates (0.36 vs. 0.41 kg/d for implanted vs. control, respect-
ively; P = 0.38). There was no interaction between level of
intake and implant status for growth rate (P = 0.38).
There was no intake × implant for serum IGF-1 levels
(P = 0.56). High-intake steers had greater IGF-1 levels
(P = 0.02) vs. low-intake steers (Figure 1). Elsasser et al.
[16] reported that greater energy intake increases circu-
lating IGF-1 levels in growing steers, and Hayden et al.
[17] reported reduced IGF-1 values in steers when intake
was restricted by 23%.
The IGF-1 concentrations in implanted steers were not
different from those in control cattle in this study. Bryant
et al. [18,19] reported no effects of implants on IGF-1 in
feedlot heifers until d 42 after implant administration;
however, Johnson et al. [18,19] and Reinhardt [20] reported
that circulating IGF-1increased in implanted steers by d 21
and d 28, respectively, compared to non-implanted steers.
Anderson et al. [21] reported that exogenous estradiol sup-
plementation in post-menopausal women increased circu-
lating growth hormone 2.1-fold but actually decreased
circulating IGF-1 by 27%.
When serum was applied to the cultured satellite cells
from the semimembranosus muscle of non-study steers,
level of intake had no effect (P = 0.85; Figure 2) on
MHC abundance but implant increased MHC abun-
dance (P < 0.01), with no interaction observed between
intake level and implant status (P = 0.23). In this study,
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Figure 1 Effects of implant or intake level on plasma urea
nitrogen. Plasma urea nitrogen concentration of steers (Chart A)
either implanted (solid line) or not implanted (dashed line) with a
long-acting TBA:E2 implant; and (Chart B) fed a common diet at
either 2.0 (solid line; HIGH) or 1.0 (dashed line; LOW) ×maintenance
NE requirements. (Effect of intake P = 0.56; implant P = 0.62; intake ×
implant P = 0.99; day × intake P < 0.01; day × implant P = 0.33; day ×
intake × implant P = 0.12. Pooled SE for treatment means was 0.261.
a,bmeans without a common superscript differ (P < 0.05).
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Figure 2 Effects of implant and intake level on myosin heavy
chain abundance in cultured myocytes. Myocytes from a non-
study steer were treated with serum (20% of total media) from study
steers drawn on d 0, 14, and 28, and myosin heavy chain abundance
was measured. In chart A, steers were either implanted (gray bars)
or not implanted (open bars) with a long-acting TBA:E2 implant; in
chart B, steers were fed a common diet at either 2.0 (gray bars;
HIGH) or 1.0 (white bars; LOW) ×maintenance NE requirements. (Effect
of day P < 0.01; intake P = 0.85; implant P < 0.01; intake × implant
P = 0.23; day × intake P = 0.88; day × implant P < 0.01; day × intake ×
implant P = 0.44; Error bars represent pooled SEM for treatment
means = 0.103).
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reflecting satellite cell proliferation and differentation.
Baxa et al. [22] found that implanting increased MHC
type IIa mRNA in vivo. In a smaller study, Baxa [23]
found that implanting with a combined estradiol-17β
(E2)/trenbolone acetate (TBA) led to numerical increases
in MHC type I and IIa mRNA. Chung et al. [24] found
no effect of E2/TBA implants on MHC type I, IIa or IIx
mRNA, but did find that MHC IIa increased over time
which was also seen in the present study (effect of day
P < 0.01). Implanting with E2/TBA increases muscle
fiber diameter [25,26], due to an initial increase in DNA
transcription followed by an increase in nuclei within
the muscle fiber which support hypertrophy, but ultim-
ately due to an increase in total protein produced by the
cell [27], of which MHC is a key constituent.
Extracellular signal-regulated kinase plays a role in
regulating insulin- and potentially IGF-I-mediated glu-
cose uptake by skeletal muscle cells [28], and certain
fatty acids reduce muscle cell proliferation via ERK [29].
Implant status did not affect the phospho-ERK abun-
dance (P = 0.46; Figure 3). Intake had no effect (P =
0.65) on phospho-ERK, and there was no interactionbetween the two main effects (P = 0.41). Because ERK is
phosphorylated (activated) by IGF-I signaling [6,30], the
lack of phospho-ERK response to implant in the present
study is understandable, given the lack of effect on circu-
lating IGF-1. However, intake level also failed to influ-
ence phospho-ERK despite the fact that HIGH increased
serum IGF-1 compared to LOW.
The protein kinase mTOR plays an essential part in
transcription, translation, muscle cell size, and protein sta-
bility [31,32]. To help regulate these processes, mTOR in-
tegrates information about nutrient status, energy status,
and many growth factors and may be a central component
in the regulation of cellular processes that determine cell
growth and proliferation, and even ultimate overall animal
size [33]. Phosphorylation of mTOR can occur at both Ser
2448 [34] and Ser 2481 [35]. We investigated Ser 2481
phosphorylation of mTOR. This site is responsive to nutri-
ent supply and Ser 2481 phosphorylation status is directly
correlated with activity of mTOR complex 1, which is re-
sponsible for promoting protein synthesis through activa-
tion of S6 kinase 1 and eukaryotic translation initiation
factor 4E-binding protein 1 [35]. There was no interaction
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Figure 3 Effect of implant and intake level on phosphorylated
extracellular signal-related kinases (phosphor-ERK). Myocytes
from a non-study steer were treated with serum (20% of total
media) from study steers drawn on d 0 and 28, and phospho-ERK
abundance was measured. Steers were (Chart A) either implanted
(gray bars) or not implanted (white bars) with a long-acting TBA:E2
implant and (Chart B) fed a common diet at either 2.0 (gray bars;
HIGH) or 1.0 × (white bars; LOW) maintenance NE requirements.
(Effect of intake P = 0.65; implant P = 0.47; intake × implant P = 0.41).
Pooled SE for treatment means was 0.065.
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Figure 4 Effects of implant and intake level on phosphorylated
mammalian target of rapamycin (phospho-mTOR) abundance
in cultured myocytes. Myocytes from a non-study steer were
treated with serum (20% of total media) from study steers drawn on
d 0 and 28. In chart A, steers were either implanted (gray bars;
IMPLANT) or not implanted (open bars; CONTROL) with a long-
acting TBA:E2 implant; in chart B, steers were fed a common diet at
either 2.0 (gray bars; HIGH) or 1.0 (white bars; LOW) ×maintenance
NE requirements. (Effect of intake P = 0.51; implant P < 0.01; intake ×
implant P = 0.88. Error bars represent pooled SEM = 0.134).
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phospho-mTOR, and intake had no effect (P = 0.51); how-
ever, serum from implanted steers (P < 0.01) stimulated
greater phospho-mTOR levels vs. serum from CONTROL
steers. Phosphorylated mTOR normally increases when
nutrition is adequate for growth and decreases when the
nutrient environment is not favorable for growth [31,36].
Although we did not see this response, it is important to
recognize that our experimental design only partially sub-
jected satellite cells to the milleu that muscle tissue of
LOW animals would have seen. Our protocol provided
cells with essentially unlimited nutrient supply via the
DMEM that comprised 80% of the media, thereby negat-
ing effects of intake level on nutrient supply to the satellite
cells. The lack of intake effect on phospho-mTOR, there-
fore, suggests only that endocrine signals (or compounds
not supplied in DMEM) that differed by intake failed to
alter satellite cell mTOR signaling. Yang et al. [32] re-
ported that mTOR is highly sensitive to upregulation by
IGF-1 and that the stress caused by low nutrient availabil-
ity can inhibit mTOR signaling. In the present study, al-
though we saw no effect of implant on IGF-1, we did
measure a strong response of implant on phospho-mTOR.
We saw a significant effect of increased intake level onIGF-1 but no corresponding effect of high nutrient intake
stimulating phospho-mTOR.
Johnson et al. [18,19] reported increased mitogenic ac-
tivity of serum from implanted vs. control steers when
applied directly to satellite cell cultures, but that study
also reported increased levels of circulating IGF-I in the
implanted steers. Results from the present study suggest
that elevated IGF-I is not the sole serum-mediated factor
which increases signalling for increased mitogenic activ-
ity in vitro, given that serum from nutrient abundant
and nutrient restricted calves, which differed greatly in
IGF-I concentration, did not alter MHC or phospho-
mTOR. The phospho-mTOR and MHC response to im-
plant, in the absence of a circulating IGF-I response,
could be explained by a number of additional, non-
somatomedin-mediated pathways associated with growth
regulation. Binding proteins specific for growth hormone
and some, although not all, for IGF-I increase in plasma
in response to elevated nutrient availability independent
of treatment with exogenous growth hormone [37], and
the same study indicated that elevated nutrient status
actually reduced growth hormone in plasma. Concentra-
tion of IGF-I mRNA is elevated in longissimus muscle
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[38,39], and muscle mRNA concentrations for the adipo-
genic regulators PPARγ and stearoyl CoA desaturase are
reduced after administration of exogenous TBA [24]. In
addition, both E2 and TBA, which were used in combin-
ation in the present study, stimulate protein synthesis
and reduce protein degradation in a dose-dependent
manner when directly applied to fused satellite cell cul-
tures [40,41]. This action is at least partially modulated
through stimulation of muscle IGF-I mRNA by E2 and
TBA [42].
Treatment of proliferating bovine satellite cells cul-
tures with either E2 or TBA resulted in increases in
IGF-1 mRNA as well as increased 3H-thymidine incorpor-
ation rate [42]. Direct treatment of fused bovine satellite
cell cultures with E2 increases protein synthesis and de-
creases protein degradation rates, and blocking of estra-
diol binding suppresses estradiol-induced modifications
in protein synthesis and degradation [40]. Testosterone
also increases satellite cell activation in rats [43]. These
documented effects indicate a direct mechanism for
both estradiol and TBA on satellite cell proliferation
and protein synthesis.
Implanting with a combination of E2 and TBA in-
creases circulating estradiol and TBA, but only exogen-
ous E2 increases circulating growth hormone [44-46].
Circulating estradiol is correlated to circulating growth
hormone in humans [47], and exogenous E2 supplemen-
tation increased growth hormone secretion in post-
menopausal women [48] and ovariectamized ewes [49].
Sotiropoulos et al. [50] reported that growth hormone
stimulates myoblast fusion with myotubes. Ge et al. [51]
reported that growth hormone did not stimulate myo-
blast fusion or proliferation, but growth hormone did in-
crease protein synthesis.
Hepatocyte growth factor increases satellite cell activa-
tion [52-54] and fibroblast growth factor enhances pro-
liferation of satellite cells in culture [55,56]. Although
hepatocyte growth factor [57-59] and fibroblast growth
factor [60,61] are elevated in vitro in response to treat-
ment with E2, liver and muscle mRNA for hepatocyte
growth factor are not affected in vivo after implanting
cattle with E2 and TBA [62].
The satellite cell results, where serum from implanted
cattle activated mTOR signaling, make it tempting to
speculate that mTOR is a more critical mediator of
muscle hypertrophy in response to implants than ERK.
Certainly, mTOR has been shown to be a key regulator
of protein synthesis [8] and is activated by testosterone
treatment [63]. The primary upstream regulators of
mTOR are AMP-activated protein kinase (AMPK), AKT,
and ERK. Blockade of either the AKT and ERK signalling
pathways ablated the mitogenic response to trenbalone
acetate in bovine satellite cells, suggesting that at leastbasal activation of both of these pathways is required
[6]. Conversely, activation of AMPK, which is triggered
by nutrient deficiency, impairs mTOR phosphorylation ,
and this pathway has been implicated in loss of muscle
mass in nutrient-restricted cows [36]. Given that implant
status did not enhance phospho-ERK abundance in this
study, we propose that basal ERK signaling was likely ne-
cessary to permit activation of mTOR, but that activa-
tion of the AKT pathway was probably more directly
involved in stimulating mTOR signaling. This is also
consistent with the unique roles of ERK and mTOR sig-
naling pathways. Although ERK does contribute to
mTOR activation, it is probably more important as a
regulator of cell proliferation [64]. Proliferation of satel-
lite cells is important for maintainance of future hyper-
trophic potential in vivo, but myotube formation is
driven by cell differentation and activation of protein
synthesis, which is more closely related to the function
of mTOR.
Conclusions
No interactions were found between nutrient restriction
and implant status in muscle satellite cell culture treated
with serum from calves either implanted or not implanted
and fed at either 1× or 2 ×maintenance. This suggests that
the effects of exogenous anabolic agents and nutrient sta-
tus on growth regulation, at least insofar as it is regulated
by the molecules measured in this study, are independent
of one another. Serum from implanted cattle promoted in-
creased abundance of the active phospho-mTOR regula-
tory protein as well as myotube formation, measured by
MHC abundance, in bovine satellite cells. These finding
suggest the presence of circulating factors in implanted
cattle that influence cell signals and promote hypertrophy
of muscle tissue.
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